AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $198.8M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 09.59am 03/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 0.0¢ | Day High | 0.0¢ | Day Low | 0.0¢ | |||
| Daily Volume | 0 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 17.0¢ | 28780 | 0 | 18.0¢ | 1926 | |
Directors & Senior Management
| Ms. Alexandra Baker-McLennan | Independent Non-Executive Director |
| Mr. Andrew Menz | CEO & Executive Director |
| Mr. Benjamin Howard Shaw | Independent Non Executive Director |
| Blake Matthews | Chief Financial Officer |
| Ms. Laura Newell | Company Secretary |
| Mr. Matthew Tripp | Executive Chairman |
| Mr. Michael Sullivan | Non-Executive Director |
| Mr. Nigel Terrence Payne | Independent Non-Executive Director |
| Mr. William Richmond | Chief Operating Officer |
Data source: ADVFN
